Compare ATYR & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | FEAM |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | United States | United States |
| Employees | 59 | 35 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 81.4M |
| IPO Year | N/A | N/A |
| Metric | ATYR | FEAM |
|---|---|---|
| Price | $0.84 | $1.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $4.20 | ★ $6.38 |
| AVG Volume (30 Days) | ★ 1.4M | 262.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9,628.95 | N/A |
| Revenue Next Year | $156.94 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $1.66 |
| 52 Week High | $7.29 | $7.50 |
| Indicator | ATYR | FEAM |
|---|---|---|
| Relative Strength Index (RSI) | 43.50 | 38.33 |
| Support Level | $0.82 | $1.66 |
| Resistance Level | $0.85 | $2.16 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 7.78 | 22.00 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.